Garmin Ltd (GRMN) has had an eventful year, with historical gains over the past year. Proposing a
$4.20 dividend, a record high for 2025, GRMN traded 4.86% higher on Apr 8, indicating significant interest from investors. The company's technical outlook appears positive due to its strong fundamentals combined with a bullish technical setup. The integration of
Natural Cycles, offering FDA-cleared birth control app functionality for select Garmin smartwatches, has sparked fresh interest. Looking forward, GRMN aims to present its first quarter 2026 earnings in an upcoming call on April 29. This comes after a noteworthy Q4 2025, where GRMN surpassed estimates and displayed increased revenue Y/Y. Valuation concerns have been mitigated as Barclays turns more constructive on GRMN. The company's shares have been upgraded by
Morgan Stanley with a new price target of $252 from $195. Institutional owners, holding 57% of the company, have seen rare inflow of investments. Lastly, Garmin's innovative vision has been recognized by awarding it as the
Most Innovative Marine Company for 2025.
Garmin Ltd GRMN News Analytics from Fri, 27 Jun 2025 07:00:00 GMT to Sat, 11 Apr 2026 23:48:16 GMT -
Innovation 8
- Information 7
- Rumor -5
